HCP Plastene Bulkpack Reports Strong Q2 FY27 Growth, Posts ₹18.35 Crore Profit

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
HCP Plastene Bulkpack Reports Strong Q2 FY27 Growth, Posts ₹18.35 Crore Profit

HCP Plastene Bulkpack reported significant year-on-year growth in its Q2 FY27 results. Both standalone and consolidated revenue and profits saw substantial increases. The company also announced management re-appointments and a CFO resignation.

HCP Plastene Bulkpack Posts Robust Q2 FY27 Financials

Standalone Revenue: ₹115.26 crore
Consolidated Net Profit: ₹18.35 crore

Reader Takeaway: Strong profit growth driven by revenue surge; CFO resignation needs monitoring.

What just happened

HCP Plastene Bulkpack Ltd. reported a strong performance for the quarter ended June 30, 2026. Standalone revenue grew to ₹115.26 crore from ₹61.52 crore in the previous comparable period. Standalone net profit surged to ₹9.00 crore from ₹0.70 crore year-on-year.

Consolidated revenue stood at ₹174.19 crore, with a net profit of ₹18.35 crore.

Why this matters

The significant year-on-year increase in both revenue and profit indicates healthy business momentum and improved operational efficiency for the company. This robust growth is a positive sign for shareholders, reflecting the company's expanding market presence.

The backstory

The company's Woven Sacks Division continues to be a primary revenue driver. This recent performance builds on its established operational strengths.

What changes now

The Board approved key management changes. Mr. Prakash Hiralal Parekh was re-appointed as Managing Director for three years from November 1, 2026. Mr. Sandeep Shah was re-appointed as Non-Executive Independent Director for five years from August 9, 2026.

However, Mr. Dhrumil Shah resigned as Chief Financial Officer effective August 12, 2026, to pursue further career opportunities. The company also noted the dissolution of its Malaysian subsidiary, HCP Plastene Bulkpack PLT, to simplify its structure.

Additionally, 16,780 equity shares were approved for allotment to employees under the ESOP scheme 2022. New Articles of Association will be adopted, subject to shareholder approval.

Risks to watch

The primary watch point for investors is the resignation of the Chief Financial Officer. This departure requires monitoring for its potential impact on financial reporting and internal controls. Ensuring a smooth transition in financial leadership is crucial.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

  • Standalone Revenue (Q2 FY26): ₹61.52 crore
  • Standalone Net Profit (Q2 FY26): ₹0.70 crore
  • Consolidated Revenue (Q2 FY26): (Not specified)
  • Consolidated Net Profit (Q2 FY26): (Not specified)

What to track next

Investors should closely monitor the transition of the CFO role and the company's sustained growth trajectory in the upcoming quarters. The successful adoption of new Articles of Association and its impact on governance will also be key to track.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.